Updates

Stepping Into Service: A Note from Our New Director of Research

John Clifton, M.D., the new Director of Research at VETS, brings a decade of experience in psychedelic healing and a vision for advancing safe, trauma-informed, and evidence-based therapies for veterans. In this welcome message, he shares his reflections on the state of the field, the urgent need for research and policy reform, and his commitment to empowering community-driven learning.

Press Release: Veterans Exploring Treatment Solutions (VETS) Leads Legislative Day of Action on March 18, 2025 in Support of Texas Ibogaine Initiative

The Legislative Day of Action aims to educate legislators on the transformative potential of ibogaine-assisted therapy for veterans struggling with OUD, co-occurring SUD, and neurological or mental health conditions, as well as address the critical issue that service members must travel internationally to access these treatments.

Press Release: Veterans Exploring Treatment Solutions (VETS) Grant Recipients Participate in Groundbreaking Stanford Study on Ibogaine Treatment for PTSD and TBI

Potent psychedelic drug banishes PTSD, small study finds

Military veterans with cognitive and psychological problems saw drastic improvements after a dose of ibogaine.

American Legion's Tango Alpha Lima Podcast: A Navy SEAL’s new mission

Retired Navy SEAL Marcus Capone finally found relief in psychedelics for his post-service transition issues. After numerous post-9/11 deployments, Capone retired in 2013 but went through a “downward spiral” for seven years before working it out. “It was a challenging time,” he says.